# Teva Parenteral Medicines, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/teva-parenteral-medicines-inc/0fca6486-3040-4806-b72d-ff1c31d675c1

> Inspection records and compliance data for Teva Parenteral Medicines, Inc. in Irvine, California. Access full analysis and detailed observations.

---

## Details

- Name: Teva Parenteral Medicines, Inc.
- FEI Number: 2027158
- City: Irvine
- State: California
- Country Name: United States
- Address Line 1: 19 Hughes
- Zip Code: 92618
- Facility Type: Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Teva Parenteral Medicines, Inc. - 2021-08-20](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/b639b463-9013-4135-a37d-81c31801d356) — source: FDA, date: August 20, 2021
- [FDA Inspection 1149378 - Teva Parenteral Medicines, Inc. - 2021-08-20](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/ff5b4440-dec5-48d1-8ee4-005907b133c2) — classification: Official Action Indicated (OAI), source: FDA, date: August 20, 2021
- [EIR - Teva Parenteral Medicines, Inc. - 2019-08-30](https://www.keypedia.com/records/eir/teva-parenteral-medicines-inc/ad108266-c6e7-4990-9ec5-b8066d2cace1) — source: FDA, date: August 30, 2019
- [483 - Teva Parenteral Medicines, Inc. - 2019-08-30](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/c0bfa6e1-e202-45f2-a51e-ce981832063d) — source: FDA, date: August 30, 2019
- [FDA Inspection 1100853 - Teva Parenteral Medicines, Inc. - 2019-08-30](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/49f583ef-bdef-4eb4-a15b-1c4e1b80b415) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2019
- [483 - Teva Parenteral Medicines, Inc. - 2019-01-18](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/dc6743ea-2a3e-415d-8ebd-114d581bd7f9) — source: FDA, date: January 18, 2019
- [FDA Inspection 997582 - Teva Parenteral Medicines, Inc. - 2016-12-19](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/b9bc1ae4-8086-411e-ac1e-a7b8ad1e81b2) — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2016
- [483 - Teva Parenteral Medicines, Inc. - 2016-07-29](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/99b91acf-e741-4421-a041-dff87c580e22) — source: FDA, date: July 29, 2016
- [FDA Inspection 980903 - Teva Parenteral Medicines, Inc. - 2016-07-29](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/f97ec7cf-8847-40d0-be26-04db2866d7a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 29, 2016
- [483 - Teva Parenteral Medicines, Inc. - 2015-07-10](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/497190da-6b42-489c-b17b-7057080cab8a) — source: FDA, date: July 10, 2015
- [FDA Inspection 882240 - Teva Parenteral Medicines, Inc. - 2014-06-06](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/27ae239e-a4e8-4b4e-929b-2568084367b8) — classification: No Action Indicated (NAI), source: FDA, date: June 6, 2014
- [483 - Teva Parenteral Medicines, Inc. - 2013-06-04](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/a341f217-c45e-4025-8a02-d53234f20847) — source: FDA, date: June 4, 2013
- [FDA Inspection 834806 - Teva Parenteral Medicines, Inc. - 2013-06-04](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/3d2dc942-c974-44a5-93ac-a292b067dfb8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 4, 2013
- [FDA Inspection 794284 - Teva Parenteral Medicines, Inc. - 2012-08-10](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/7bc3431c-fbb8-4568-98e7-efe2fe9a095b) — classification: No Action Indicated (NAI), source: FDA, date: August 10, 2012
- [483 - Teva Parenteral Medicines, Inc. - 2012-04-24](https://www.keypedia.com/records/483/teva-parenteral-medicines-inc/f7a6bed1-b9b0-4d1c-9a00-118a6663a935) — source: FDA, date: April 24, 2012
- [EIR - Teva Parenteral Medicines, Inc. - 2012-04-24](https://www.keypedia.com/records/eir/teva-parenteral-medicines-inc/b299d610-ae8c-472a-874f-b86459f675d6) — source: FDA, date: April 24, 2012
- [FDA Inspection 779321 - Teva Parenteral Medicines, Inc. - 2012-04-24](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/cbf10a34-d00d-4548-bb82-13db30750338) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 24, 2012
- [EIR - Teva Parenteral Medicines, Inc. - 2010-05-14](https://www.keypedia.com/records/eir/teva-parenteral-medicines-inc/6a358c56-b202-4ff2-beac-e0b9413decf7) — source: FDA, date: May 14, 2010
- [FDA Inspection 661280 - Teva Parenteral Medicines, Inc. - 2010-05-14](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/045d8480-b3ff-4cc7-871b-a8e3a14f4951) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 14, 2010
- [FDA Inspection 661280 - Teva Parenteral Medicines, Inc. - 2010-05-14](https://www.keypedia.com/records/fda_inspections/teva-parenteral-medicines-inc/b5b66ccb-7e32-4c9b-ac6b-26a418b72458) — classification: No Action Indicated (NAI), source: FDA, date: May 14, 2010

## Related Companies

- [ICON Laboratory Services, Inc.](https://www.keypedia.com/companies/icon-laboratory-services-inc/c186271a-4150-430b-90f5-2c41b012e330)
- [Blue Bell Creameries, LP](https://www.keypedia.com/companies/blue-bell-creameries-lp/72914afe-a234-40c1-9dcb-7c916c53020f)
- [Labcorp Early Development Laboratories, Inc.](https://www.keypedia.com/companies/labcorp-early-development-laboratories-inc/fd7a8136-483e-4368-bbf9-d12f2e2ca1f2)
- [LEESAR, INC](https://www.keypedia.com/companies/leesar-inc/275b969d-7cd2-4c17-af66-d7ed6ff4dec1)
- [Blue Bell Creameries, L.P.](https://www.keypedia.com/companies/blue-bell-creameries-lp/f947ab98-3399-4fe6-b8eb-59b6313dc9b4)
- [Triangle Compounding Pharmacy Inc](https://www.keypedia.com/companies/triangle-compounding-pharmacy-inc/8d7934f5-3b37-4d56-8ba4-77445eb5b9a9)
- [I.T.S. GmbH](https://www.keypedia.com/companies/its-gmbh/222e9947-d8bf-4009-9811-979b8bd114c6)
- [BlendHouse LLC](https://www.keypedia.com/companies/blendhouse-llc/3237d3bd-3b9c-4067-9a6b-a89b8bdb7de5)
- [Peregrina Cheese Corp.](https://www.keypedia.com/companies/peregrina-cheese-corp/8f2bc1c5-a49d-46ec-8342-c62719566da9)
- [SCA Pharmaceuticals, Inc.](https://www.keypedia.com/companies/sca-pharmaceuticals-inc/2ef86fd7-d7d9-4bed-9ad6-24594b9b1f94)

## Related Officers

- [Caryn Mcnab](https://www.keypedia.com/people/caryn-mcnab/05d5f65d-5ab2-4798-a3a2-2798a82237e1)
- [Laboratory Director](https://www.keypedia.com/people/jennifer-m-gogley/2025f306-80a6-4222-89ac-e4138028292a)
- [Consumer Safety Officer (Drug Specialist)](https://www.keypedia.com/people/alan-p-kurtzberg/36ee316e-6d19-44b2-a131-fc254ada4f41)
- [SVP Consulting & Operations](https://www.keypedia.com/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2)
- [company_representative](https://www.keypedia.com/people/paul-smith/240c4178-4d99-411e-8ecc-9ed865e0cd1c)
- [company_representative](https://www.keypedia.com/people/manjula-ghosh/26b4f832-70fe-4394-96f9-40be06f334c4)